Aflatoxin B1 alters the expression of p53 in cytochrome P450-expressing human lung cells

被引:36
|
作者
Van Vleet, TR
Watterson, TL
Klein, PJ
Coulombe, RA
机构
[1] Utah State Univ, Grad Program Toxicol, Logan, UT 84322 USA
[2] Utah State Univ, Dept Vet Sci, Logan, UT 84322 USA
关键词
D O I
10.1093/toxsci/kfj039
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Aflatoxin B-1 (AFB(1)) is a potent dietary hepatocarcinogen in animals and probably in humans. Mutations (and altered expression) of the tumor suppresser gene p53 have been observed in liver tumors from patients exposed to high dietary AFB(1). Inhalation of AFB(1)-laden grain dusts has been associated with an increased incidence of lung cancer in humans as well. We examined the effects of low concentrations of AFB(1) on the expression of p53 and MDM2 in human bronchial epithelial cells (BEAS-2B) transfected with cDNA for either cytochrome P450 (CYP) 1A2 (B-CMV1A2) or CYP 3A4 (B3A4), two isozymes that are responsible for AFB(1) activation in human liver and possibly the lung. Untreated B-CMV1A2 and B3A4 cells constitutively expressed p53. Exposure to a range (0.015-15 mu M for 30 min) of AFB(1) concentrations caused a concentration-dependent decline in p53 expression in B-CMV1A2 cells, and to a lesser extent, in B3A4 cells. The AFB(1)-mediated decrease in p53 continued for at least 12 h after 30-min exposures to 1.5 mu M AFB(1). Mirroring the decrease in p53 expression was a concentration-dependent increase in the expression of the 76-kDa MDM2 isoform in B-CMV1A2 and B-3A4 cells. Interestingly, AFB(1) did not induce DNA laddering, an indicator of apoptotic cell death, but proteolytic activation of caspase-3 was detected in AFB(1)-treated B-CVM1A2 cells. In total, these data show that low, environmentally-relevant concentrations of AFB(1) alter the expression of p53 and MDM2 in these human lung cells, and that cells that stably express CYP 1A2 were more susceptible to this effect than nontransfected, or 3A4-expressing cells.
引用
收藏
页码:399 / 407
页数:9
相关论文
共 50 条
  • [41] Fumonisin B1 modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b
    Chuturgoon, Anil A.
    Phulukdaree, Alisa
    Moodley, Devapregasan
    TOXICOLOGY LETTERS, 2014, 227 (01) : 50 - 55
  • [42] DETECTION OF HUMAN LUNG CYTOCHROMES-P450 THAT ARE IMMUNOCHEMICALLY RELATED TO CYTOCHROME-P450IIE1 AND CYTOCHROME-P450IIIA
    WHEELER, CW
    WRIGHTON, SA
    GUENTHNER, TM
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (01) : 183 - 186
  • [43] Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer
    Oyama, T
    Morita, M
    Isse, T
    Kagawa, N
    Nakata, S
    So, T
    Mizukami, M
    Ichiki, Y
    Ono, K
    Sugaya, M
    Uramoto, H
    Yoshimatsu, T
    Hanagiri, T
    Sugio, K
    Kawamoto, T
    Yasumoto, K
    FRONTIERS IN BIOSCIENCE, 2005, 10 : 1156 - 1161
  • [44] Characterization of cytochrome P450 expression in human urothelial cells
    Tschirbs, S.
    Doerrenhaus, A.
    Roos, P. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 71 - 72
  • [45] Expression of cytochrome P450 in lung tumor
    Gharavi, N
    El-Kadi, AOS
    CURRENT DRUG METABOLISM, 2004, 5 (02) : 203 - 210
  • [46] KINDS OF MUTATIONS INDUCED BY AFLATOXIN-B1 IN A SHUTTLE VECTOR REPLICATING IN HUMAN-CELLS TRANSIENTLY EXPRESSING CYTOCHROME-P450IA2 CDNA
    TROTTIER, Y
    WAITHE, WI
    ANDERSON, A
    MOLECULAR CARCINOGENESIS, 1992, 6 (02) : 140 - 147
  • [47] Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes
    Kim, BR
    Kim, DH
    Park, R
    Kwon, KB
    Ryu, DG
    Kim, YC
    Kim, NY
    Jeong, S
    Kang, BK
    Kim, KS
    PLANTA MEDICA, 2001, 67 (05) : 396 - 399
  • [48] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [49] Cyclin B1 Expression and p53 Status in Squamous Cell Carcinomas of the Head and Neck
    Hoffmann, Thomas K.
    Trellakis, Sokratis
    Okulicz, Kornelia
    Schuler, Patrick
    Greve, Jens
    Arnolds, Judith
    Bergmann, Christoph
    Bas, Murat
    Lang, Stephan
    Lehnerdt, Goetz
    Brandau, Sven
    Mattheis, Stefan
    Scheckenbach, Kathrin
    Finn, Oliviera J.
    Whiteside, Theresa L.
    Sonkoly, Eniko
    ANTICANCER RESEARCH, 2011, 31 (10) : 3151 - 3157
  • [50] WAF1 expression is independent of p53 gene alterations and protein expression in human lung cancer cells
    Mukhopadhyay, T
    Roth, JA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (03) : 405 - 410